Now is the time to be part of a global social awareness movement.

Be part of a mentality change in health care. The European Social Charter, deals with social and medical assistance. It stipulates basic medical care as a human right, which is an important contribution to social peace, rather than a business model. This statement does not imply that we shall neglect health economic aspects, rather we keep them in the back of our minds.

Join our team and become a member of our non-profit organizations in Germany and Switzerland. Enrich us with your creativity, your knowledge and long standing professional experience as a physician, pharmacist, researcher, copywriter, lawyer, tax consultant, social worker, health economist, as a student, during your professional life or during your retirement. Take part in our activities focusing on clinical research and development for humanitarian purposes in disease indications neglected by industrial Research and Development (R&D).

Due to the policy change of WHO, focusing on the improvement of skin wound management not only for Leishmania but of all neglected tropical skin diseases (NTDs), we have joined the NNN skin cross cutting group to extend our expertise from Leishmania wounds to all neglected skin lesions.

Because of the security decline in Afghanistan, we have shifted our attention and activities to Middle Eastern and North African (MENA) countries. They are not only close to Europe; they have become important for Europe. Through them, Europe can exert a positive influence on healthcare development in Africa giving the people peace, new hope and perspectives in their home countries. Education, healthcare and social justice contribute to peace within societies.


Temporary Market Access granted by BfArM for the Medical Device, LeiProtect®

The use of LeiProtect® has been legalized on August 28th, 2017 (91.1.07-5640-S-006/16) by the Institut für Arzneimittel und Meidizinprodukte (BfArM) according to § 11 of the Medical Device Regulation (MPG). It is currently used to protect leishmaniasis skin lesions from superinfections, thus promoting their healing, … Continue reading “Temporary Market Access granted by BfArM for the Medical Device, LeiProtect®”